Chemical and Pharmaceutical Bulletin
Online ISSN : 1347-5223
Print ISSN : 0009-2363
ISSN-L : 0009-2363
Purification and Some Properties of Ketone Reductase Forming an Active Metabolite of Sodium 2-[4-(2-Oxocyclopentylmethyl)-phenyl] propionate Dihydrate (Loxoprofen Sodium), a New Anti-inflammatory Agent, in Rabbit Liver Cytosol
田中 頼久西川 優子松田 啓一山崎 光郎林 了三
著者情報
キーワード: substrate specificity
ジャーナル フリー

1984 年 32 巻 3 号 p. 1040-1048

詳細
抄録
The enzyme which catalyzes the reduction of the cyclopentanone moiety of sodium 2-[4-(2-oxocyclopentylmethyl) phenyl] propionate dihydrate (loxoprofen sodium) was purified from rabbit liver cytosol to homogeneity as judged by polyacrylamide gel electrophoresis. The purified enzyme had a molecular weight of 33000, showed a preference for nicotineamide adenine dinucleotide phosphate as a cofactor and had an optimal pH of 6.2. The Km and Vmax values for the reduction of loxoprofen were 0.45mM and 0.81 μmol/min/mg protein, and the trans-alcohol was the main product. The reducing activity was inhibited by p-chloromercuribenzoate, N-ethylmaleimide and quercitrin. The enzyme efficiently catalyzed reduction of various aromatic aldehydes and ketones, cyclohexanones and 5α-3-ketosteroids. Cyclopentanone and its methylsubstituted derivatives were not reduced at all. However, 2-ethyl-and 2-n-propylcyclopentanone were reduced, and 2-benzylcyclopentanone was a good substrate, comparable to loxoprofen itself. These results strongly suggest that the loxoprofen reducing enzyme is probably identical with the aromatic aldehyde-ketone reductase (F3) of rabbit liver cytosol, identified as 3α-hydroxysteroid dehydrogenase by Sawada et al.
著者関連情報
© The Pharmaceutical Society of Japan
前の記事 次の記事
feedback
Top